A new study indicates hydroxychloroquine may reduce the Covid-19 death rate by 50%:
nypost.com
As a result, the FDA may reverse its disapproval of this drug. The question remains whether it will cause serious psychological side effects in those patients already suffering from TDS.
![nypost.com](https://nypost.com/wp-content/uploads/sites/2/2020/07/hydroxychloroquine.jpg?quality=75&strip=all&w=1024)
Hydroxychloroquine can help save hospitalized coronavirus patients, study finds
A team at Henry Ford Health System in Southeast Michigan said Thursday that a study of 2,541 hospitalized patients found that those given the drug were far less likely to die, CNN reported.
![nypost.com](https://nypost.com/wp-content/themes/nypost-2016/static/images/apple-icons/nypost/apple-icon.png)